Wellington Management Group LLP Adicet Bio, Inc. Transaction History

Wellington Management Group LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.13 - $7.13 $584,642 - $1.96 Million	274,480 Added 54.7%	776,305 $1.89 Million
Q1 2023 May 12, 2023	SELL	$5.52 - $9.23 $1.67 Million - $2.78 Million	-301,733 Reduced 37.55%	501,825 $2.89 Million
Q4 2022 Feb 13, 2023	BUY	$7.72 - $21.27 $6.2 Million - $17.1 Million	803,558 New	803,558 $7.18 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $39.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.